𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Natalizumab and primary central nervous system lymphoma revisited

✍ Scribed by Andreas Schweikert; Muna Hoshi; Bernhard Hemmer; Achim Berthele


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
95 KB
Volume
69
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Primary central nervous system lymphoma
✍ Andreas Schweikert; Marcus Kremer; Florian Ringel; Thomas Liebig; Justus Duyster πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 182 KB πŸ‘ 2 views

## Abstract A 40‐year‐old man with relapsing‐remitting multiple sclerosis (MS) developed primary central nervous system lymphoma (PCNSL) after having received 21 doses of natalizumab monotherapy. PCNSL is a disease of the elderly, with the majority of patients being diagnosed in the 7th to 8th deca

Primary central nervous system lymphoma
✍ Yinjun Lou; Jie Jin; Shusen Zheng; Renya Zhan; LiJun Wang πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 187 KB πŸ‘ 2 views

A 51-year-old Chinese man underwent an orthotopic liver transplantation for liver carcinoma that developed in the setting of cirrhosis linked to HBV infection. The Image 1. Image 2. Image 3.

Primary central nervous system lymphoma
✍ Lisa M. Deangelis πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 491 KB πŸ‘ 2 views

Primary central nervous system lymphoma (PCNSL) is a rare neoplasm, but it is occurring with increased frequency even among apparently immunocompetent patients. Although secondary malignancies frequently involve the lymphoreticular system, PCNSL has been reported as a second neoplasm only once previ